Intelligence Β· Patent portfolio
Nektar Therapeutics UK Patents
Full USPTO pharma patent portfolio for Nektar Therapeutics UK β grant dates, expiration, and drug cross-links.
- Patents
- 423
- Expiring β€24m
- 24
Quick answer
Nektar Therapeutics UK has 423 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 24 expire within 24 months β use filters for patent-cliff planning.
-
US 7101932
Method for the preparation of 1-benzotriazolyl carbonate esters of poly (ethylene glycol)
granted -
US 7078496
Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith
granted -
US 7060259
Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
granted -
US 7056500
Polymer conjugates of opioid antagonists
granted -
US 7053150
Segmented polymers and their conjugates
granted -
US 7030278
Polyethylene(Glycol) derivatives with proximal reactive groups
expired -
US 7026440
Branched polymers and their conjugates
expired -
US 6992168
Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof
expired -
US 6946117
Stabilized preparations for use in nebulizers
expired -
US 6921527
Composition for pulmonary administration comprising a drug and a hydrophobic amino acid
expired -
US 6911197
N-maleimidyl polymer derivatives
expired -
US 6908963
Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith
expired -
US 6899898
Induced phase transition method for the production of microparticles containing hydrophobic active agents
expired -
US 6899867
Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
expired -
US 6896906
Storage stable powder compositions of interleukin-4 receptor
expired -
US 6894025
Biologically active molecules having thiol moiety conjugated to polymers containing ethyl sulfone moiety
expired -
US 6890518
Compositions of chemically modified insulin
expired -
US 6864350
Soluble, degradable poly (ethylene glycol) derivatives for controllable release of bound molecules into solution
expired -
US 6860907
Method of particle formation
expired -
US 6838528
Multi-arm block copolymers as drug delivery vehicles
expired -
US 6838076
Pulmonary administration of chemically modified insulin
expired -
US 6838075
Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
expired -
US 6835372
Compositions comprising an active agent
expired -
US 6825031
Storage of materials
expired -
US 6797258
Compositions and methods for the pulmonary delivery of aerosolized macromolecules
expired -
US 6774180
Synthesis of high molecular weight non-peptidic polymer derivatives
expired -
US 6737045
Methods and compositions for the pulmonary delivery insulin
expired -
US 6737505
Sterically hindered poly(ethylene glycol) alkanoic acids and derivatives thereof
expired -
US 6730334
Multi-arm block copolymers as drug delivery vehicles
expired -
US 6710125
Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)
expired -
US 6685967
Methods and compositions for pulmonary delivery of insulin
expired -
US 6673335
Compositions and methods for the pulmonary delivery of aerosolized medicaments
expired -
US 6664331
Poly(ethylene glycol) derivatives with proximal reactive groups
expired -
US 6655379
Aerosolized active agent delivery
expired -
US 6638495
Stabilized preparation for use in metered dose inhalers
expired -
US 6630169
Particulate delivery systems and methods of use
expired -
US 6589560
Stable glassy state powder formulations
expired -
US 6576262
Methods and apparatus for particle formation
expired -
US 6569406
Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
expired
Frequently asked questions
How many patents does Nektar Therapeutics UK have?
423 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Nektar Therapeutics UK patents expire?
24 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory